Glufosfamide Completed Phase 2 Trials for Lung Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00005055 | Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer |